Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.59 +0.05 (+2.91%)
As of: Oct 2, 2026 · 10:52 AM EDT

Transcode Therapeutics (RNAZ) Depreciation & Amortization (CF) (2021 - 2026)

Updated

Transcode Therapeutics (RNAZ) recorded Depreciation & Amortization (CF) of $23,937 in Q2 2026, up 78.1% from $13,443 a year earlier and unchanged from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

On a TTM basis, Transcode Therapeutics' Depreciation & Amortization (CF) came in at $34,431 as of Jun 30, 2026, down 35.4% year-over-year; for FY2025, it came in at $13,443, down 85.2% from FY2024.

  • Annual Depreciation & Amortization (CF) has a four-year compound annual growth rate of -25.0% (FY2021 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $90,894 in FY2024 (-26.4%), $123,483 in FY2023 (+25.2%), $98,606 in FY2022 (+132.2%) and $42,470 in FY2021.
  • The Q2 2026 figure is the highest quarterly Depreciation & Amortization (CF) since Q2 2024.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in two of the last seven quarters, with an average decline of 21.0%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 383.7% in Q2 2022, against a decline of 70.2% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $23,936 (Q1 2026), -$18,223 (Q4 2025) and $4,781 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - 23,937.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,937.00
Mar 31, 2026 23,936.00
Dec 31, 2025 -18,223.00
Sep 30, 2025 4,781.00
Jun 30, 2025 13,443.00
Mar 31, 2025 13,443.00
Dec 31, 2024 10,346.00
Sep 30, 2024 16,031.00
Jun 30, 2024 32,354.00
Mar 31, 2024 32,164.00
Dec 31, 2023 31,655.00
Sep 30, 2023 31,218.00
Jun 30, 2023 30,970.00
Mar 31, 2023 29,640.00
Dec 31, 2022 29,505.00
Sep 30, 2022 24,802.00
Jun 30, 2022 22,698.00
Mar 31, 2022 21,601.00
Dec 31, 2021 28,988.00
Sep 30, 2021 7,535.00
API Access

Transcode Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RNAZ&period=max&api_key=YOUR_API_KEY